1 completed, 1 recruiting. 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Recruiting 1 |
Follow Methylphenidate Hydrochloride Extended Release Capsule: new trials by email Literature Review of Methylphenidate Hydrochloride Extended Release Capsule trials Research Report on Methylphenidate Hydrochloride Extended Release Capsule
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Open-Label Treatment With Randomization Observation, Investigator-Initiated Study, on the Duration and Efficacy of Jornay PM (Methylphenidate Hydrochloride Extended-Release Capsules) on Adult ADHD Symptoms and Executive Function and Emotional Regulation Throughout the Day Into Early Evening Methylphenidate Hydrochloride Extended Release Capsule - Attention-deficit/Hyperactivity Disorder | Phase 4 | Recruiting | NYU Langone Health | 30 | 2025-01-29 | 2026-04-29 |
| Time Course of Response to Methylphenidate HCl ER Capsules in Children 6 to 12 Years With ADHD in Classroom Setting Methylphenidate Hydrochloride Extended Release Capsule, Placebo - Attention Deficit Hyperactivity Disorder, ADHD | Phase 3 | Completed | Rhodes Pharmaceuticals, L.P. | 26 | 2011-01-19 | 2022-12-13 |
Attention Deficit Disorder with Hyperactivity (2) · Impulsive Behavior (1) · Spasm (1)
NYU Langone Health (1) · Rhodes Pharmaceuticals, L.P. (1)
United States (2)
Lenard Adler, MD (1) · Robert Kupper, Ph.D. (1) · Sharon B. Wigal, Ph.D. (1) · Wei-wei Chang, Ph.D. (1)